The U.S. Food and Drug Administration has approved Iterum Therapeutics' oral antibiotic to treat certain types of bacterial ...

Veterinarians should become familiar with new definitions and recommendations for managing urinary tract infections in dogs ...

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company ...

Recurrent urinary tract infections affect kidney function in children with vesicoureteral reflux. Antibiotics can protect ...

This is the first approved indication for Orlynvah and the first FDA-approved product for Iterum. "We are so pleased to have achieved this historic milestone and would like to thank all the patients, ...

Application supported by positive results from pivotal phase III EAGLE-2 and EAGLE-3 trials26 March 2025 assigned as action ...

If you have diarrhoea-causing E.coli, you will have a runny stomach, pains and cramps, loss of appetite and low fever. If the ...

The global urinary tract infection (UTI) treatment market is expected to expand steadily over the next decade, with an estimated valuation of USD 11,244.0 million in 2024. According to recent market ...

In 2021, the FDA rejected the oral antibiotic based on mixed data from another phase III trial and recommended that Iterum ...

Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum ...

The FDA granted Priority Review to gepotidacin for the treatment of female adults and adolescents with uncomplicated UTI.